BioCentury | Oct 13, 2017
Financial News

Angle completes placings

...Oct. 12 following the sale of 7.5 million shares at 37.5p to an additional investor. finnCap...
BioCentury | Aug 8, 2011
Analyst Picks & Changes

Analyst picks & changes

...Peterson also lowered his 2012 revenue estimate to $77M from $139M. Vectura Group plc (LSE:VEC) FinnCap...
BioCentury | Apr 11, 2011
Company News

IS Pharma, Sinclair deal

...while IS Pharma shareholders would own the remaining 36.7%. Sinclair Capital Markets advised Sinclair, while finnCap...
BioCentury | Nov 15, 2010
Financial News

IS Pharma completes placing

...£12.5 million ($20.1 million) Shares: 15.6 million Price: 80p Shares after offering: 51 million Underwriter: FinnCap WIR...
BioCentury | Nov 11, 2010
Financial News

IS Pharma raises L12.5 million

...through the sale of 15.6 million shares at 80p per share in a private placement. FinnCap...
Items per page:
1 - 5 of 5
BioCentury | Oct 13, 2017
Financial News

Angle completes placings

...Oct. 12 following the sale of 7.5 million shares at 37.5p to an additional investor. finnCap...
BioCentury | Aug 8, 2011
Analyst Picks & Changes

Analyst picks & changes

...Peterson also lowered his 2012 revenue estimate to $77M from $139M. Vectura Group plc (LSE:VEC) FinnCap...
BioCentury | Apr 11, 2011
Company News

IS Pharma, Sinclair deal

...while IS Pharma shareholders would own the remaining 36.7%. Sinclair Capital Markets advised Sinclair, while finnCap...
BioCentury | Nov 15, 2010
Financial News

IS Pharma completes placing

...£12.5 million ($20.1 million) Shares: 15.6 million Price: 80p Shares after offering: 51 million Underwriter: FinnCap WIR...
BioCentury | Nov 11, 2010
Financial News

IS Pharma raises L12.5 million

...through the sale of 15.6 million shares at 80p per share in a private placement. FinnCap...
Items per page:
1 - 5 of 5